carnitine has been researched along with metformin in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 4 (23.53) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Horikawa, M; Ishiwata, N; Kato, Y; Matsubara, K; Nakamichi, N; Silver, DL; Sugiura, T; Takeuchi, K; Umeda, S | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| McCarty, MF | 1 |
| Dhawan, A; Dziechciarz, P; Horvath, A; Socha, P; Szajewska, H; Vajro, P | 1 |
| Ajmo, I; Laliberté, M; Poirier, D; St-Onge, M | 1 |
| Choi, SH; Hong, ES; Jang, HC; Kang, SM; Khang, AR; Kim, EK; Lim, S; Park, KS | 1 |
| Futatsugi, A; Kato, Y; Kawabata, S; Masuo, Y; Nakamichi, N | 1 |
| Barger, JL; Cray, NL; Hester, SN; Mastaloudis, A; Newton, MA; Prolla, TA; Pugh, TD; Vann, JM; Weindruch, R; Wood, SM | 1 |
| Al-Majdoub, M; Ali, A; Carstensen, B; Ridderstråle, M; Safai, N; Spégel, P; Suvitaival, T; Vestergaard, H | 1 |
| Abd El Latif, HA; AinShoka, AA; El Shazly, KA; Zayed, EA | 1 |
| El Sharkwy, I; Sharaf El-Din, M | 1 |
| Costales, C; Holliman, CL; Horlbogen, L; Luo, L; Mathialagan, S; Ramanathan, R; Rodrigues, AD; Vourvahis, M | 1 |
| Abediankenari, S; Dashti, A; Majidi, FZ; Rezaei, N; Shafaroudi, MM; Zare, Z | 1 |
| Liang, WC; Liao, WA; Lin, PY; Sun, YT | 1 |
| Bazarganipour, F; Jahanfar, S; Taghavi, SA; van Wely, M | 1 |
3 review(s) available for carnitine and metformin
| Article | Year |
|---|---|
Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review.
Topics: Acetylcysteine; Adult; Alanine Transaminase; Aspartate Aminotransferases; Carnitine; Child; Dietary Supplements; Drug Synergism; Drug Therapy, Combination; Fatty Liver; Humans; Hypoglycemic Agents; Liver; Metformin; Pioglitazone; Probucol; Randomized Controlled Trials as Topic; Thiazolidinediones; Ursodeoxycholic Acid; Vitamin E | 2009 |
L-Carnitine for the treatment of a calcium channel blocker and metformin poisoning.
Topics: Aged; Antidotes; Antihypertensive Agents; Calcium Channel Blockers; Carnitine; Combined Modality Therapy; Drug Overdose; Drug Resistance; Ethanol; Humans; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Insulin Resistance; Male; Metformin; Shock; Suicide, Attempted; Treatment Outcome; Vitamin B Complex | 2013 |
Pharmacological and non-pharmacological strategies for obese women with subfertility.
Topics: Abortion, Spontaneous; Appetite Depressants; Bias; Carnitine; Clomiphene; Dexfenfluramine; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Infertility, Female; Life Style; Liraglutide; Live Birth; Mental Health; Metformin; Obesity; Pregnancy; Quality of Life; Randomized Controlled Trials as Topic; Weight Loss | 2021 |
3 trial(s) available for carnitine and metformin
| Article | Year |
|---|---|
Effect of carnitine-orotate complex on glucose metabolism and fatty liver: a double-blind, placebo-controlled study.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Blood Glucose; Carnitine; DNA Copy Number Variations; DNA, Mitochondrial; Double-Blind Method; Drug Combinations; Endpoint Determination; Fasting; Fatty Liver; Female; Glucose Metabolism Disorders; Glycated Hemoglobin; Humans; Insulin Resistance; Male; Metformin; Middle Aged; Orotic Acid; Oxidative Stress; Placebo Effect | 2014 |
Effect of metformin on plasma metabolite profile in the Copenhagen Insulin and Metformin Therapy (CIMT) trial.
Topics: Aged; Carnitine; Chromatography, Liquid; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Isoleucine; Leucine; Lysophospholipids; Male; Mass Spectrometry; Metabolome; Metabolomics; Metformin; Middle Aged; Mitochondria; Tyrosine; Valine | 2018 |
l-Carnitine plus metformin in clomiphene-resistant obese PCOS women, reproductive and metabolic effects: a randomized clinical trial.
Topics: Adult; Blood Glucose; Carnitine; Clomiphene; Drug Resistance; Female; Fertility Agents, Female; Hormones; Humans; Infertility, Female; Insulin Resistance; Metformin; Obesity; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Reproduction; Treatment Outcome; Young Adult | 2019 |
11 other study(ies) available for carnitine and metformin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent.
Topics: Animals; Benzoates; Blood Platelets; Cell Line; Dose-Response Relationship, Drug; Hepatocytes; Humans; Hydrazines; Injections, Intravenous; Intracellular Signaling Peptides and Proteins; Liver; Liver-Specific Organic Anion Transporter 1; Male; Membrane Proteins; Mice; Mice, Knockout; Organic Anion Transporters; Organic Cation Transporter 1; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Thrombopoietin; Tissue Distribution | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Utility of metformin as an adjunct to hydroxycitrate/carnitine for reducing body fat in diabetics.
Topics: Adipose Tissue; Body Composition; Carnitine; Citrates; Diabetes Mellitus; Humans; Hypoglycemic Agents; Metformin; Models, Biological; Obesity; Weight Loss | 1998 |
L503F variant of carnitine/organic cation transporter 1 efficiently transports metformin and other biguanides.
Topics: Amines; Asian People; Biguanides; Biological Transport, Active; Buformin; Carnitine; Cyclohexanecarboxylic Acids; Ergothioneine; Gabapentin; gamma-Aminobutyric Acid; HEK293 Cells; Humans; Intestinal Absorption; Metformin; Organic Cation Transporter 1; Polymorphism, Single Nucleotide; White People | 2016 |
Identification of tissue-specific transcriptional markers of caloric restriction in the mouse and their use to evaluate caloric restriction mimetics.
Topics: 2,4-Dinitrophenol; Adipose Tissue, White; Aging; Animals; Bezafibrate; Caloric Restriction; Carnitine; Citrate (si)-Synthase; Gene Expression Profiling; Gene Expression Regulation; Glycated Hemoglobin; Interferon-gamma; Male; Metformin; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Mice, Inbred Strains; Muscle, Skeletal; Myocardium; Neocortex; Pioglitazone; Quercetin; Resveratrol; Sirtuin 3; Stilbenes; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2017 |
Improvement of insulin resistance via increase of GLUT4 and PPARγ in metabolic syndrome-induced rats treated with omega-3 fatty acid or l-carnitine.
Topics: Adiposity; Animals; Carnitine; Diet, Carbohydrate Loading; Diet, High-Fat; Dietary Supplements; Fatty Acids, Omega-3; Fructose; Glucose Transporter Type 4; Heart; Hypoglycemic Agents; Insulin Resistance; Intra-Abdominal Fat; Liver; Male; Metabolic Syndrome; Metformin; Myocardium; Organ Size; PPAR gamma; Random Allocation; Rats, Sprague-Dawley | 2018 |
A Multiplexed HILIC-MS/HRMS Assay for the Assessment of Transporter Inhibition Biomarkers in Phase I Clinical Trials: Isobutyryl-Carnitine as an Organic Cation Transporter (OCT1) Biomarker.
Topics: Biomarkers; Carnitine; Clinical Trials, Phase I as Topic; Drug Interactions; Enzyme Inhibitors; Humans; Metformin; Organic Cation Transport Proteins; Organic Cation Transporter 1; Organic Cation Transporter 2 | 2020 |
The Protective Effects of L-Carnitine and Zinc Oxide Nanoparticles Against Diabetic Injury on Sex Steroid Hormones Levels, Oxidative Stress, and Ovarian Histopathological Changes in Rat.
Topics: Animals; Antioxidants; Biomarkers; Blood Glucose; Carnitine; Diabetes Mellitus, Experimental; Female; Gonadal Steroid Hormones; Hypoglycemic Agents; Lipid Peroxidation; Metal Nanoparticles; Metformin; Ovarian Diseases; Ovary; Oxidative Stress; Rats, Wistar; Zinc Oxide | 2021 |
Exacerbation of myopathy triggered by antiobesity drugs in a patient with multiple acyl-CoA dehydrogenase deficiency.
Topics: Adult; Anti-Obesity Agents; Asian People; Carnitine; Female; Humans; Metformin; Multiple Acyl Coenzyme A Dehydrogenase Deficiency; Muscle Weakness; Muscular Diseases; Riboflavin; Topiramate; Triiodothyronine; Ubiquinone | 2021 |